Trial reveals sirolimus-coated balloons outperform paclitaxel devices in three-year leg artery study
A three-year clinical trial reveals that patients treated with sirolimus-coated balloons experienced an eight-percentage-point advantage in avoiding repeat procedures compared to those receiving paclitaxel-coated balloons. Both treatments delivered comparable gains in patient walking ability and quality of life. Researchers emphasize that these findings still require validation through five-year follow-up evaluations.
Open for the full story →